Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong-yang Wang

Showing results (221-230 of 248) with videos related to

Pageof 25
Sort By:
Theranostics|July 9, 2019
Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinomaYan-Jing Zhu, Bo Zheng, Gui-Juan Luo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 21, 2022
Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine StarvationHui-Lu Zhang, Ping Chen, He-Xin Yan, et al.
Cancer Management and Research|August 9, 2020
Effect of the Standardized Management of Cancer Pain on Patients with Bone Metastasis of Lung Cancer in ChinaJing-Jing Jin, Tian-Tian Xu, Yan-Fang Li, et al.
Journal of Hepatology|April 14, 2015
PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patientsTao Han, Dai-Min Xiang, Wen Sun, et al.
Hepatology (Baltimore, Md.)|June 4, 2013
Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinomaWen-Ping Xu, Min Yi, Qian-Qian Li, et al.
Gastroenterology|January 10, 2017
Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor ProgressionXi-Meng Lin, Liang Hu, Jin Gu, et al.
Clinical and Translational Medicine|May 1, 2021
4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-αShu-Zhen Chen, Yan Ling, Le-Xing Yu, et al.
Gut|July 30, 2017
The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosisDai-Min Xiang, Wen Sun, Bei-Fang Ning, et al.
Oncotarget|January 9, 2016
HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stressMing-Da Wang, Han Wu, Shuai Huang, et al.
Hepatology (Baltimore, Md.)|July 18, 2017
Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significanceXiao-Feng Li, Cheng Chen, Dai-Min Xiang, et al.
Pageof 25

Showing results (221-230 of 248) with videos related to

Sort By:
Pageof 25
Theranostics|July 9, 2019
Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinomaYan-Jing Zhu, Bo Zheng, Gui-Juan Luo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 21, 2022
Targeting mTORC2/HDAC3 Inhibits Stemness of Liver Cancer Cells Against Glutamine StarvationHui-Lu Zhang, Ping Chen, He-Xin Yan, et al.
Cancer Management and Research|August 9, 2020
Effect of the Standardized Management of Cancer Pain on Patients with Bone Metastasis of Lung Cancer in ChinaJing-Jing Jin, Tian-Tian Xu, Yan-Fang Li, et al.
Journal of Hepatology|April 14, 2015
PTPN11/Shp2 overexpression enhances liver cancer progression and predicts poor prognosis of patientsTao Han, Dai-Min Xiang, Wen Sun, et al.
Hepatology (Baltimore, Md.)|June 4, 2013
Perturbation of MicroRNA-370/Lin-28 homolog A/nuclear factor kappa B regulatory circuit contributes to the development of hepatocellular carcinomaWen-Ping Xu, Min Yi, Qian-Qian Li, et al.
Gastroenterology|January 10, 2017
Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor ProgressionXi-Meng Lin, Liang Hu, Jin Gu, et al.
Clinical and Translational Medicine|May 1, 2021
4-phenylbutyric acid promotes hepatocellular carcinoma via initiating cancer stem cells through activation of PPAR-αShu-Zhen Chen, Yan Ling, Le-Xing Yu, et al.
Gut|July 30, 2017
The HLF/IL-6/STAT3 feedforward circuit drives hepatic stellate cell activation to promote liver fibrosisDai-Min Xiang, Wen Sun, Bei-Fang Ning, et al.
Oncotarget|January 9, 2016
HBx regulates fatty acid oxidation to promote hepatocellular carcinoma survival during metabolic stressMing-Da Wang, Han Wu, Shuai Huang, et al.
Hepatology (Baltimore, Md.)|July 18, 2017
Chronic inflammation-elicited liver progenitor cell conversion to liver cancer stem cell with clinical significanceXiao-Feng Li, Cheng Chen, Dai-Min Xiang, et al.
Pageof 25